Android app on Google Play

sanofi-aventis (SNY) To Reduce U.S. Workforce by 25%; Will Refocus U.S. Ops on Three Areas

October 8, 2010 11:08 AM EDT Send to a Friend
Get Alerts SNY Hot Sheet
Trade SNY Now!
Join SI Premium – FREE
Sanofi-aventis' (NYSE: SNY) U.S. division announced that they would be streamlining their operations in lieu of the challenging healthcare marketplace.

The restructuring will include an estimated 25% work force reduction in U.S. Pharmaceutical Operations, eliminating approximately 1,700 positions in total. These decisions will be finalized by mid-December.

Also, the focus of U.S. Pharmaceuticals will be Diabetes, Atrial Fibrillation and Oncology.

You May Also Be Interested In

Related Categories

Corporate News

Add Your Comment